rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
Intramural Research Programs of the National Institutes of Health (NIH), including the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
PubMed
38298111
PubMed Central
PMC11005728
DOI
10.1002/advs.202308280
Knihovny.cz E-zdroje
- Klíčová slova
- dendritic cells, glioblastoma, immunotherapy, rWTC‐MBTA vaccine, tumor microenvironment,
- MeSH
- CD8-pozitivní T-lymfocyty MeSH
- dendritické buňky MeSH
- glioblastom * metabolismus MeSH
- imunita MeSH
- myši MeSH
- nádorové mikroprostředí MeSH
- vakcíny * metabolismus MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- vakcíny * MeSH
Despite strides in immunotherapy, glioblastoma multiforme (GBM) remains challenging due to low inherent immunogenicity and suppressive tumor microenvironment. Converting "cold" GBMs to "hot" is crucial for immune activation and improved outcomes. This study comprehensively characterized a therapeutic vaccination strategy for preclinical GBM models. The vaccine consists of Mannan-BAM-anchored irradiated whole tumor cells, Toll-like receptor ligands [lipoteichoic acid (LTA), polyinosinic-polycytidylic acid (Poly (I:C)), and resiquimod (R-848)], and anti-CD40 agonistic antibody (rWTC-MBTA). Intracranial GBM models (GL261, SB28 cells) are used to evaluate the vaccine efficacy. A substantial number of vaccinated mice exhibited complete regression of GBM tumors in a T-cell-dependent manner, with no significant toxicity. Long-term tumor-specific immune memory is confirmed upon tumor rechallenge. In the vaccine-draining lymph nodes of the SB28 model, rWTC-MBTA vaccination triggered a major rise in conventional dendritic cell type 1 (cDC1) 12 h post-treatment, followed by an increase in conventional dendritic cell type 2 (cDC2), monocyte-derived dendritic cell (moDC), and plasmacytoid dendritic cell (pDC) on Day 5 and Day 13. Enhanced cytotoxicity of CD4+ and CD8+ T cells in vaccinated mice is verified in co-culture with tumor cells. Analyses of immunosuppressive signals (T-cell exhaustion, myeloid-derived suppressor cells (MDSC), M2 macrophages) in the GBM microenvironment suggest potential combinations with other immunotherapies for enhanced efficacy. In conclusion, the authors findings demonstrate that rWTC-MBTA induces potent and long-term adaptive immune responses against GBM.
Zobrazit více v PubMed
Stupp R., Mason W. P., Van Den Bent M. J., Weller M., Fisher B., Taphoorn M. J. B., Belanger K., Brandes A. A., Marosi C., Bogdahn U., Curschmann J., Janzer R. C., Ludwin S. K., Gorlia T., Allgeier A., Lacombe D., Cairncross J. G., Eisenhauer E., Mirimanoff R. O., N. Engl. J. Med. 2005, 352, 987. PubMed
Yaghi N. K., Gilbert M. R., Biomedicines 2022, 10, 427. PubMed
Zhao B., Zhao H., Zhao J., Ther Adv Med Oncol 2020, 12, 175883592093761.
Camacho L. H., Cancer Med. 2015, 4, 661. PubMed PMC
Yang T., Kong Z., Ma W., Hum Vaccin Immunother 2021, 17, 546. PubMed PMC
Maggs L., Cattaneo G., Dal A. E., Moghaddam A. S., Ferrone S., Front Neurosci 2021, 15, 662064. PubMed PMC
Sampson J. H., Gunn M. D., Fecci P. E., Ashley D. M., Nat. Rev. Cancer 2020, 20, 12. PubMed PMC
Lim M., Xia Y., Bettegowda C., Weller M., Nat. Rev. Clin. Oncol. 2018, 15, 422. PubMed
Tomaszewski W., Sanchez‐Perez L., Gajewski T. F., Sampson J. H., Clin. Cancer Res. 2019, 25, 4202. PubMed PMC
Lohr J., Ratliff T., Huppertz A., Ge Y., Dictus C., Ahmadi R., Grau S., Hiraoka N., Eckstein V., Ecker R. C., Korff T., Von Deimling A., Unterberg A., Beckhove P., Herold‐Mende C., Clin. Cancer Res. 2011, 17, 4296. PubMed
Antonarelli G., Corti C., Tarantino P., Ascione L., Cortes J., Romero P., Mittendorf E. A., Disis M. L., Curigliano G., Ann. Oncol. 2021, 32, 1537. PubMed PMC
Pérez‐Baños A., Gleisner M. A., Flores I., Pereda C., Navarrete M., Araya J. P., Navarro G., Quezada‐Monrás C., Tittarelli A., Salazar‐Onfray F., Br. J. Cancer 2023, 129, 572. PubMed PMC
Liau L. M., Ashkan K., Tran D. D., Campian J. L., Trusheim J. E., Cobbs C. S., Heth J. A., Salacz M., Taylor S., D'andre S. D., Iwamoto F. M., Dropcho E. J., Moshel Y. A., Walter K. A., Pillainayagam C. P., Aiken R., Chaudhary R., Goldlust S. A., Bota D. A., Duic P., Grewal J., Elinzano H., Toms S. A., Lillehei K. O., Mikkelsen T., Walbert T., Abram S. R., Brenner A. J., Brem S., Ewend M. G., et al., J. Transl. Med. 2018, 16, 142. PubMed PMC
Liau L. M., Ashkan K., Brem S., Campian J. L., Trusheim J. E., Iwamoto F. M., Tran D. D., Ansstas G., Cobbs C. S., Heth J. A., Salacz M. E., D'andre S., Aiken R. D., Moshel Y. A., Nam J. Y., Pillainayagam C. P., Wagner S. A., Walter K. A., Chaudhary R., Goldlust S. A., Lee I. Y., Bota D. A., Elinzano H., Grewal J., Lillehei K., Mikkelsen T., Walbert T., Abram S., Brenner A. J., Ewend M. G., et al., JAMA Oncol 2023, 9, 112. PubMed PMC
Schaller T. H., Sampson J. H., Expert Rev. Vaccines 2017, 16, 27. PubMed PMC
Eisenbarth S. C., Nat. Rev. Immunol. 2019, 19, 89. PubMed PMC
Satpathy A. T., Wu X., Albring J. C., Murphy K. M., Nat. Immunol. 2012, 13, 1145. PubMed PMC
Doebel T., Voisin B., Nagao K., Trends Immunol. 2017, 38, 817. PubMed
Cabeza‐Cabrerizo M., Cardoso A., Minutti C. M., Pereira da Costa M., Reis e Sousa C., Dendritic Cells Revisited. Annu Rev Immunol 2021, 39, 166. PubMed
Bowman‐Kirigin J. A., Desai R., Saunders B. T., Wang A. Z., Schaettler M. O., Liu C. J., Livingstone A. J., Kobayashi D. K., Durai V., Kretzer N. M., Cancer Immunol Res 2023, 11, 37. PubMed PMC
Medina R., Wang H., Caisova V., Cui J., Indig I. H., Uher O., Ye J., Nwankwo A., Sanchez V., Wu T., Adv. Ther. (Weinh) 2020, 3. PubMed PMC
Lechner M. G., Karimi S. S., Barry‐Holson K., Angell T. E., Murphy K. A., Church C. H., Ohlfest J. R., Hu P., Epstein A. L., J. Immunother. 2013, 36, 477. PubMed PMC
Ye J., Wang H., Medina R., Chakraborty S., Sun M., Valenzuela A., Sang X., Zhang Y., Uher O., Zenka J., Pacak K., Zhuang Z., J. Exp. Clin. Cancer Res. 2023, 42, 163. PubMed PMC
Sharma P., Aaroe A., Liang J., Puduvalli V. K., Neurooncol Adv. 2023, 5, vdad009. PubMed PMC
Watowich M. B., Gilbert M. R., Larion M., Trends Cancer 2023, 9, 270. PubMed PMC
Hatano M., Kuwashima N., Tatsumi T., Dusak J. E., Nishimura F., Reilly K. M., Storkus W. J., Okada H., J. Transl. Med. 2004, 2, 40. PubMed PMC
Belmans J., Van Woensel M., Creyns B., Dejaegher J., Bullens D. M., Van Gool S. W., Sci. Rep. 2017, 7, 13902. PubMed PMC
Johanns T. M., Ward J. P., Miller C. A., Wilson C., Kobayashi D. K., Bender D., Fu Y., Alexandrov A., Mardis E. R., Artyomov M. N., Schreiber R. D., Dunn G. P., Cancer Immunol. Res. 2016, 4, 1007. PubMed PMC
Genoud V., Marinari E., Nikolaev S. I., Castle J. C., Bukur V., Dietrich P.‐Y., Okada H., Walker P. R., Oncoimmunology 2018, 7, e1501137. PubMed PMC
Wouters R., Bevers S., Riva M., De Smet F., Coosemans A., Cancers (Basel) 2020, 13, 19. PubMed PMC
Luksik A. S., Yazigi E., Shah P., Jackson C. M., Cancers (Basel) 2023, 15. PubMed PMC
Sheng K.‐C., Pouniotis D. S., Wright M. D., Tang C. K., Lazoura E., Pietersz G. A., Apostolopoulos V., Immunology 2006, 118, 372. PubMed PMC
Longhi M. P., Trumpfheller C., Idoyaga J., Caskey M., Matos I., Kluger C., Salazar A. M., Colonna M., Steinman R. M., J. Exp. Med. 2009, 206, 1589. PubMed PMC
Gladue R. P., Paradis T., Cole S. H., Donovan C., Nelson R., Alpert R., Gardner J., Natoli E., Elliott E., Shepard R., Bedian V., Cancer Immunol. Immunother. 2011, 60, 1009. PubMed PMC
Edwards A. D., Diebold S. S., Slack E. M. C., Tomizawa H., Hemmi H., Kaisho T., Akira S., Sousa C. R. E., Eur. J. Immunol. 2003, 33, 827. PubMed
Schulz O., Diebold S. S., Chen M., Näslund T. I., Nolte M. A., Alexopoulou L., Azuma Y.‐T., Flavell R. A., Liljeström P., Reis E Sousa C., Nature 2005, 433, 887. PubMed
Wang X., Wu K., Keeler S. P., Mao D., Agapov E. V., Zhang Y., Holtzman M. J., J. Immunol. 2021, 206, 1297. PubMed PMC
Schreibelt G., Tel J., Sliepen K. H. E. W. J., Benitez‐Ribas D., Figdor C. G., Adema G. J., De Vries I. J. M., Cancer Immunol. Immunother. 2010, 59, 1573. PubMed PMC
Antonios J. P., Soto H., Everson R. G., Moughon D., Orpilla J. R., Shin N. P., Sedighim S., Treger J., Odesa S., Tucker A., Neuro Oncol 2017, 19, 796. PubMed PMC
Medina R., Wang H., Caisová V., Cui J., Indig I. H., Uher O., Ye J., Nwankwo A., Sanchez V., Wu T., Advanced Therapeutics 2020, 3. PubMed PMC